Your position:
m.limatoxi.com
>>
EN
>>
Pharmaceutical News
>>
Industry
>>
Wuzhong Pharma to begin phase Ⅲ trial of rhEn for lung cancer
>> article
Wuzhong Pharma to begin phase Ⅲ trial of rhEn for lung cancer
Editor:bianch Clicks:
0
Date:2011-3-4 15:52:43
Keyword:
recombinant human endostatin rhEn
Healthoo Information:
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Dongbao's recombinant insulin got EU GMP&...
Wanbang to expand insulin capacity
New insulin facility completed construction
Market situation of human serum albumin ...
Shiyao building Recombinant Recombinant Salmon&nbs...
Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
